A Case of Renal stones during treatment with Zonisamide
Journal of the Korean Neurological Association
;
: 601-602, 1998.
Article
in Korean
| WPRIM
| ID: wpr-101810
ABSTRACT
Following its approval in Japan, zonisamide (Excegran ) has been accepted as a new antiepileptic drug having broad spectrum activity. However, it does not have marketing approval in the US. Clinical trials were suspended in the US because of the high incidence of renal stone development (3.7%). We experienced a case of renal calculus which was identified during the course of zonisamide treatment. We believe this is the first case report of renal stone development suspecting the causal relation to the zonisamide treatment in Korea.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Kidney Calculi
/
Incidence
/
Marketing
/
Epilepsy
/
Japan
/
Korea
Type of study:
Incidence study
/
Prognostic study
Country/Region as subject:
Asia
Language:
Korean
Journal:
Journal of the Korean Neurological Association
Year:
1998
Type:
Article
Similar
MEDLINE
...
LILACS
LIS